Charite University Hospital Berlin
Department of Nuclear Medicine (278012)
Specialized in: nuclear medicine
The Department of Nuclear Medicine at the Charite University Hospital under the direction of Prof. Dr. med Winfried Brenner offers the entire spectrum of radioisotope diagnosis and radionuclide therapy. In the field of diagnostic imaging, the Department of Nuclear Medicine is equipped with the state-of-the-art two-chamber systems of single-photon emission computed tomography (SPECT) in its all three units, including a few hybrid SPECT/CT – systems of innovative construction, as well as the advanced PET/CT – (PET: positron emission tomography) systems with the Time-of-Flight function for the highest image quality. In addition, the department has a few radiochemical modules, including a cyclotron for the formation of radioactive isotopes for imaging by means of SPECT and PET, as well as for the development of radioisotope drugs.
Within the framework of nuclear medicine, the department supervises the unit with 17 beds. This unit provides all standard radioisotopes, for example, for thyroid disease, as well as a wide range of new treatment options, such as radioimmunotherapy for lymphomas, radiopeptide therapy for neuroendocrine tumors or selective internal radiation therapy (SIRT) for primary liver tumors and liver metastasis.
In addition to the general range of conventional nuclear diagnosis and PET/CT, the Department offers the following complex therapies:
- Radioiodine therapy for benign thyroid diseases or thyroid cancer
- Radiopeptide receptor therapy for neuroendocrine tumors
- Selective internal radiation therapy (SIRT) for multiple liver metastases
- MIBG (metaiodobenzylguanidine) for neuroblastomas
- Radiosynovectomy as intra-articular therapy
- Treatment for CD20-positive lymphomas
- Palliative pain therapy for bone metastases
- Berlin, Germany